Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

Hered Cancer Clin Pract. 2021 Sep 8;19(1):37. doi: 10.1186/s13053-021-00195-w.

Krithika Murali¹, Tanya M Dwarte^{2

3

4}, Mehrdad Nikfarjam⁵, Katherine M Tucker^{3

6}, Rhys B Vaughan⁷, Marios Efthymiou⁷, Allison Collins⁸, Allan D Spigelman^{6

9}, Lucinda Salmon¹, Amber L Johns², David B Williams⁴, Martin B Delatycki¹, Thomas John¹⁰, Alina Stoita^{11

12}

¹ Department of Clinical Genetics, Austin Health, Heidelberg, VIC, 3084, Australia.
² Australian Pancreatic Cancer Genome Initiative, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.
³ Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, NSW, 2031, Australia.
⁴ Department of Gastroenterology, St Vincent's Hospital, Darlinghurst, NSW, 2010, Australia.
⁵ Division of Surgery, Austin Health, Heidelberg, VIC, 3084, Australia.
⁶ University of New South Wales, St Vincent's Clinical School and Prince of Wales Clinical School, Randwick, NSW, 2031, Australia.
⁷ Department of Gastroenterology, Austin Health, Heidelberg, VIC, 3084, Australia.
⁸ Clinical Trials Unit, Olivia Newton John Cancer and Wellness Centre, Austin Health, Heidelberg, VIC, 3084, Australia.
⁹ Cancer Genetics Unit, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, 2010, Australia.
¹⁰ Peter MacCallum Cancer Centre, Parkville, VIC, 3000, Australia.
¹¹ Department of Gastroenterology, St Vincent's Hospital, Darlinghurst, NSW, 2010, Australia. alina.stoita@svha.org.au.
¹² University of New South Wales, St Vincent's Clinical School and Prince of Wales Clinical School, Randwick, NSW, 2031, Australia. alina.stoita@svha.org.au.

No abstract available

Publication types